article · 2014
Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis
In active RA patients with an incomplete MTX response, CZP 200 mg every 2 weeks and 400 mg every 4 weeks were comparable and better than placebo for maintain...
14 citationsDOI: https://doi.org/10.1002/acr.22496Open accessPDF reported by metadataFull text reported by metadata